Brittany Gehm
Nurse Practitioner · Mountain Lakes, NJNPI 1295113934
Payments from drug & device makers
Across 471 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$894
- AstraZeneca$795
- Daiichi Sankyo Inc.$604
- Novartis$482
- GSK$397
- Amgen$362
- plus $4K from 54 others
What the payments were for
- Food & beverage$7,86699%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,966 in reported general payments places this provider in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PomalystPomalidomide | 84 | $1,882,097 |
| RevlimidLenalidomide | 107 | $1,661,958 |
| ProcritEpoetin Alfa | 166 | $547,725 |
| BrukinsaZanubrutinib | 27 | $385,538 |
| ImbruvicaIbrutinib | 18 | $355,059 |
| JakafiRuxolitinib Phosphate | 24 | $346,802 |
| RydaptMidostaurin | 14 | $339,796 |
| CalquenceAcalabrutinib Maleate | 21 | $302,661 |
| NeulastaPegfilgrastim | 31 | $297,701 |
| Neulasta OnproPegfilgrastim | 42 | $284,645 |
| LumakrasSotorasib | 12 | $246,495 |
| IbrancePalbociclib | 13 | $199,320 |
| TagrissoOsimertinib Mesylate | 12 | $189,585 |
| ZirabevBevacizumab-Bvzr | 16 | $173,866 |
| XtandiEnzalutamide | 12 | $171,704 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| E.r. Squibb & Sons, L.L.C.Pomalyst | $894 | $1,882,09784 claims |
| Bristol Myers SquibbRevlimid | $92 | $1,661,958107 claims |
| Johnson & JohnsonProcrit, Xarelto | $352 | $573,727201 claims |
| AmgenNeulasta, Lumakras | $362 | $544,19643 claims |
| AstraZenecaCalquence, Tagrisso | $795 | $492,24633 claims |
| PfizerIbrance, Zirabev, Trazimera, Eliquis | $54 | $491,478101 claims |
| Beigene USA, Inc.Brukinsa | $91 | $385,53827 claims |
| Pharmacyclics LLC, An Abbvie CompanyImbruvica | $167 | $355,05918 claims |
| Incyte CorporationJakafi | $270 | $346,80224 claims |
| NovartisRydapt | $482 | $339,79614 claims |
| Astellas Pharma US IncXtandi | $174 | $171,70412 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $33 | $132,89713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.
Other nurse practitioner in Mountain Lakes
- Nancy BonnetMorristown$407K
- Vanessa CoppolaCloster$205K
- Olufunmilayo IloriUnion$133K
- Janice BeitzHaddon Heights$75K
- Adewale AdefowojuUnion$70K
- Sophia KimEnglewood$70K
- Elizabeth FletcherCamden$62K
- Lannae EwingLinwood$39K
- Beth SavageNew Brunswick$34K
- Tina OcchiutoMorristown$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.